A 6-year-old boy was referred to our hospital with reduced range of motion of the hand for over 2 years. Otherwise, he did not have muscle weakness or myalgia. Except for a history of atopic dermatitis, he was healthy and had no family history of similar conditions. At his first visit of our hospital, he did not take any topical steroids or immunosuppressants. Physical examination revealed symmetrical swellings of metacarpophalangeal joint, proximal interphalangeal joints, and the knee joints, and their range of motion was limited without muscle weakness. Symmetrical hyperkeratotic flat red papules were noticed on the dorsum of his fingers on hands, the extensor surfaces of elbows and knees (Fig. 1a, b). Laboratory test results were within normal limits including muscle enzymes and were negative for rheumatoid factor and HLA-B27 was negative; however, antinuclear antibodies were positive, and slit lamp examination showed no signs of uveitis. Histological examination of a biopsy of the skin lesion on the hand was consistent with that of psoriasis (Fig. 1c, d). Ultrasound confirmed intra-articular effusion of the knee joint. Contrast-enhanced magnetic resonance imaging of both knees showed contrast-enhanced lesions in the upper edge of the patella and the ligaments between the patella, roughened tibia, and synovial membrane but did not involve the muscles. Hence, he was diagnosed with juvenile psoriatic arthritis (JPsA). Treatment with methotrexate was initiated, and adalimumab was added later. His arthritis improved and is now well controlled in over 2 years of follow-up.
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.